13:23:08 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2024-11-13 Kvartalsrapport 2024-Q3
2024-08-27 Kvartalsrapport 2024-Q2
2024-05-08 Kvartalsrapport 2024-Q1
2024-05-02 Ordinarie utdelning LIFE 0.00 NOK
2024-04-30 Årsstämma 2024
2024-02-27 Bokslutskommuniké 2023
2023-11-14 Kvartalsrapport 2023-Q3
2023-08-23 Kvartalsrapport 2023-Q2
2023-05-11 Kvartalsrapport 2023-Q1
2023-05-08 Ordinarie utdelning LIFE 0.00 NOK
2023-04-18 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-09 Ordinarie utdelning LIFE 0.00 NOK
2022-05-06 Årsstämma 2022
2022-04-21 Bokslutskommuniké 2021
2021-09-30 Extra Bolagsstämma 2021
2021-08-05 Kvartalsrapport 2021-Q2
2021-05-10 Ordinarie utdelning LIFE 0.00 NOK
2021-05-07 Årsstämma 2021
2021-04-20 Bokslutskommuniké 2020
2020-06-26 Årsstämma 2020
2020-06-01 Bokslutskommuniké 2019
2019-02-07 Split LIFE 4:1
2018-12-11 Extra Bolagsstämma 2018

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriMedicinteknik
Lifecare är ett norskt bolag verksamma inom medicinteknik. Idag är bolaget specialiserade inom forskning och utveckling av diabetes. Produkterna är patenterade och används som glukosgivare. Mikrosensorerna injiceras under huden på patientens handled, och fungerar vidare som en realtidsuppdatering av glukosnivån i patienten. Utöver bidrar tekniken med larmsensor samt tillgång till historisk data över patientens glukosnivå. Bolaget etablerades under 2006 och har sitt huvudkontor i Bergen, Norge.
2021-10-25 14:45:00
Bergen 25 October 2021

Lifecare AS' management team will host an online presentation on Wednesday 10
November 2021.

The webcast will be for all shareholders and interested parties at 11:00 - 11:30
CET. The presentation will give an operational update for the third quarter.
There will be a Q&A session following the management presentation. The link to
the webcast will be available in the Investors section
https://lifecare.no/events/operational-update-3-quarter-2021/

You can post questions during the event or send them in advance to:
kine.hereid@lifecare.no

Lifecare AS' CSO Prof. Andreas Pfützner will present at the 20th annual Diabetes
Tech Meeting hosted by Diabetes Technology Society at 4-6 November 2021. Topic
of the presentation will be the EU funded project Forget Diabetes: a novel
automated insulin delivery system, of which Lifecare in cooperation with 6
academic partners cross Europe aim to develop an artificial pancreas where the
sensing system is based on the Sencell technology. The presentation will be
given on 6 November at 10:00 am (Pacific Time) and will give an overview of the
project.

The Diabetes Tech Meeting host leading scientists in the field of diabetes
research and they present the latest technological advances for people with
diabetes. Last year's meeting brought together over 500 clinicians and
scientists from 20 countries to focus on applying science and technology to
fight diabetes. The goal of the meeting is to connect technology developers and
users to facilitate the creation of new and cost-effective tools to help people
with diabetes.

Lifecare's Board member Prof. Lutz Heinemann will also present at the annual
Diabetes Tech Meeting, he will make several appearances, his topics will be
emerging technologies, bruising and green diabetes.


Further information
Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no, +47 40 05 90 40

This stock exchange announcement was published by Kine Hereid, Investor
Relations at Lifecare AS, on 25.10.2021 at 14:45 CET.